Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 16.4% in October

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 374,100 shares, a growth of 16.4% from the October 15th total of 321,500 shares. Currently, 18.7% of the company’s shares are sold short. Based on an average trading volume of 180,600 shares, the days-to-cover ratio is presently 2.1 days.

Sunshine Biopharma Price Performance

Sunshine Biopharma stock traded down $0.22 during mid-day trading on Friday, hitting $2.35. The stock had a trading volume of 311,442 shares, compared to its average volume of 137,349. The stock has a 50-day simple moving average of $2.92 and a two-hundred day simple moving average of $1.72. Sunshine Biopharma has a 12 month low of $2.25 and a 12 month high of $637.20.

Sunshine Biopharma (NASDAQ:SBFM) last issued its earnings results on Tuesday, November 5th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing the consensus estimate of $9.00 by ($9.94). The business had revenue of $8.44 million during the quarter. Sunshine Biopharma had a negative net margin of 12.82% and a negative return on equity of 17.89%.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.